Cargando…

Dual dose-dependent effects of fingolimod in a mouse model of Alzheimer’s disease

Lipid metabolism is abnormal in Alzheimer’s disease (AD) brain leading to ceramide and sphingosine accumulation and reduced levels of brain sphingosine-1-phosphate (S1P). We hypothesize that changes in S1P signaling are central to the inflammatory and immune-pathogenesis of AD and the therapeutic be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carreras, Isabel, Aytan, Nurgul, Choi, Ji-Kyung, Tognoni, Christina M., Kowall, Neil W., Jenkins, Bruce G., Dedeoglu, Alpaslan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662857/ https://www.ncbi.nlm.nih.gov/pubmed/31358793 http://dx.doi.org/10.1038/s41598-019-47287-1

Ejemplares similares

Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer’s disease
por: Aytan, Nurgul, et al.
Publicado: (2016)

Microglial response to experimental periodontitis in a murine model of Alzheimer’s disease
por: Kantarci, Alpdogan, et al.
Publicado: (2020)

Microglial cell response to experimental periodontal disease
por: Almarhoumi, Rawan, et al.
Publicado: (2023)

A Preliminary Study of Cu Exposure Effects upon Alzheimer’s Amyloid Pathology
por: Pilozzi, Alexander, et al.
Publicado: (2020)

Time- and Sex-Dependent Effects of Fingolimod Treatment in a Mouse Model of Alzheimer’s Disease
por: Bascuñana, Pablo, et al.
Publicado: (2023)

The Periodontal Pathogen Fusobacterium nucleatum Exacerbates Alzheimer’s Pathogenesis via Specific Pathways
por: Wu, Hongle, et al.
Publicado: (2022)

Determination of Seminal Concentration of Fingolimod and Fingolimod‐Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod
por: David, Olivier J., et al.
Publicado: (2017)

Fingolimod Rescues Demyelination in a Mouse Model of Krabbe's Disease
por: Béchet, Sibylle, et al.
Publicado: (2020)

Fingolimod Modulates Dendritic Architecture in a BDNF-Dependent Manner
por: Patnaik, Abhisarika, et al.
Publicado: (2020)

Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease
por: Zhu, H, et al.
Publicado: (2015)

Fingolimod and Teriflunomide Attenuate Neurodegeneration in Mouse Models of Neuronal Ceroid Lipofuscinosis
por: Groh, Janos, et al.
Publicado: (2017)

The effect of fingolimod on regulatory T cells in a mouse model of brain ischaemia
por: Malone, Kyle, et al.
Publicado: (2021)

Progressive multifocal leukoencephalopathy after fingolimod treatment
por: Berger, Joseph R., et al.
Publicado: (2018)

Use of a Biomarker in Exposure–Response Analysis to Support Dose Selection for Fingolimod
por: Lee, J-Y, et al.
Publicado: (2013)

The First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis Patients
por: Sáenz-Cuesta, Matías, et al.
Publicado: (2018)

Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review
por: Ghadiri, Fereshteh, et al.
Publicado: (2023)

Reversing Alzheimer's disease dementia with clemastine, fingolimod, or rolipram, plus anti‐amyloid therapy
por: Fessel, Jeffrey
Publicado: (2022)

Acute onset of fingolimod-associated macular edema
por: Soliman, Mohamed Kamel, et al.
Publicado: (2016)

Fingolimod therapy is not effective in a mouse model of spontaneous autoimmune peripheral polyneuropathy
por: Huehnchen, Petra, et al.
Publicado: (2018)

Fingolimod induces neurogenesis in adult mouse hippocampus and improves contextual fear memory
por: Efstathopoulos, P, et al.
Publicado: (2015)

Antidepressant activity of fingolimod in mice
por: di Nuzzo, Luigi, et al.
Publicado: (2015)

Fingolimod for Irradiation-Induced Neurodegeneration
por: Metzdorf, Judith, et al.
Publicado: (2019)

Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial
por: Laroni, Alice, et al.
Publicado: (2014)

Fingolimod Affects Transcription of Genes Encoding Enzymes of Ceramide Metabolism in Animal Model of Alzheimer’s Disease
por: Jęśko, Henryk, et al.
Publicado: (2020)

An observational study of alemtuzumab following fingolimod for multiple sclerosis
por: Willis, Mark, et al.
Publicado: (2017)

Modulation of Cardiac Autonomic Function by Fingolimod Initiation and Predictors for Fingolimod Induced Bradycardia in Patients with Multiple Sclerosis
por: Li, Kai, et al.
Publicado: (2017)

Cryptococcal Meningitis Reported With Fingolimod Treatment: Case Series
por: Del Poeta, Maurizio, et al.
Publicado: (2022)

Neurological safety of fingolimod: An updated review
por: Yoshii, Fumihito, et al.
Publicado: (2017)

Fingolimod Rescues Memory and Improves Pathological Hallmarks in the 3xTg-AD Model of Alzheimer’s Disease
por: Fagan, Steven G., et al.
Publicado: (2022)

Electrocardiographic assessments and cardiac events after fingolimod first dose – a comprehensive monitoring study
por: Limmroth, Volker, et al.
Publicado: (2017)

Neuroprotective Effects of Fingolimod Supplement on the Retina and Optic Nerve in the Mouse Model of Experimental Autoimmune Encephalomyelitis
por: Yang, Tao, et al.
Publicado: (2021)

Modulatory Effects of Fingolimod (FTY720) on the Expression of Sphingolipid Metabolism-Related Genes in an Animal Model of Alzheimer’s Disease
por: Jęśko, Henryk, et al.
Publicado: (2018)

Intermittent Atrioventricular Block following Fingolimod Initiation
por: Gialafos, E., et al.
Publicado: (2014)

Vagomimetic Effects of Fingolimod: Physiology and Clinical Implications
por: Vanoli, Emilio, et al.
Publicado: (2014)

Efficacy and Safety of Fingolimod in an Unselected Patient Population
por: Rasenack, Maria, et al.
Publicado: (2016)

Cardiovascular effects of fingolimod: A review article
por: Behjati, Mohaddeseh, et al.
Publicado: (2014)

Fingolimod induces neuroprotective factors in human astrocytes
por: Hoffmann, Franziska S., et al.
Publicado: (2015)

Fingolimod Augments Monomethylfumarate Killing of GBM Cells
por: Dent, Paul, et al.
Publicado: (2020)

Fingolimod in children with Rett syndrome: the FINGORETT study
por: Naegelin, Yvonne, et al.
Publicado: (2021)

Multiple Sclerosis Relapses Following Cessation of Fingolimod
por: Malpas, Charles B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m7rmjpdga1786d6mp19qt8co27